
Victory Square Technologies announced strong fiscal 2025 results, led by Hydreight Technologies' revenue doubling to $35.4M and improved profitability with adjusted EBITDA rising to $2.5M. The growth reflects scaling of the VSDHOne healthcare platform across the U.S., enabling compliant digital health services. Victory Square also advanced its portfolio including Insu Therapeutics and Pawsible Ventures, focusing on healthcare infrastructure and pet health. Hydreight projects 2026 revenue around $150M, signaling continued expansion and operational leverage in digital health infrastructure.